The Incremental Health Care Costs of Frailty Among Home Care Recipients With and Without Dementia in Ontario, Canada: A Cohort Study.


Journal

Medical care
ISSN: 1537-1948
Titre abrégé: Med Care
Pays: United States
ID NLM: 0230027

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 21 5 2019
medline: 12 11 2019
entrez: 21 5 2019
Statut: ppublish

Résumé

In this study, we investigated the incremental 1-year direct costs of health care associated with frailty among home care recipients in Ontario with and without dementia. We conducted a cohort study of 159,570 home care clients aged 50 years and older in Ontario, Canada in 2014/2015. At index home care assessment, we ascertained dementia status using a validated algorithm and frailty level (robust, prefrail, frail) based on the proportion of accumulated to potential health deficits. Clients were followed for 1-year during which we obtained direct overall and sector-specific publicly-funded health care costs (in 2015 Canadian dollars). We estimated the incremental effect of frailty level on costs using a 3-part survival- and covariate-adjusted estimator. All analyses were stratified by dementia status. Among those with dementia (n=42,828), frailty prevalence was 32.1% and the average 1-year cost was $30,472. The incremental cost of frailty (vs. robust) was $10,845 [95% confidence interval (CI): $10,112-$11,698]. Among those without dementia (n=116,742), frailty prevalence was 25.6% and the average 1-year cost was $28,969. Here, the incremental cost of frailty (vs. robust) was $12,360 (95% CI: $11,849-$12,981). Large differences in survival between frailty levels reduced incremental cost estimates, particularly for the dementia group (survival effect: -$2742; 95% CI: -$2914 to -$2554). Frailty was associated with greater 1-year health care costs for persons with and without dementia. This difference was driven by a greater intensity of health care utilization among frail clients. Mortality differences across the frailty levels mitigated the association especially among those with dementia.

Identifiants

pubmed: 31107398
doi: 10.1097/MLR.0000000000001139
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

512-520

Auteurs

Luke Mondor (L)

ICES.
Health System Performance Research Network (HSPRN), Toronto.

Colleen J Maxwell (CJ)

ICES.
Health System Performance Research Network (HSPRN), Toronto.
Schools of Pharmacy and Public Health & Health Systems, University of Waterloo, Waterloo, ON.

David B Hogan (DB)

Division of Geriatric Medicine, Department of Medicine, University of Calgary, Calgary, AB.

Susan E Bronskill (SE)

ICES.
Health System Performance Research Network (HSPRN), Toronto.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto.

Dallas P Seitz (DP)

Division of Geriatric Psychiatry, Queen's University & Providence Care Hospital, Kingston.

Walter P Wodchis (WP)

ICES.
Health System Performance Research Network (HSPRN), Toronto.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto.
Institute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH